GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, ...

Overview of Short Bowel Syndrome MarketThe Global Short Bowel Syndrome Market is valued at USD 1.76 Billion in 2024 and is projected to attain a value of USD 3.66 Billion by 2035 at a CAGR of 6.91% ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...